Form4insider filings, from the source

SEC Form 4 · accession 0001126234-15-000006

NEWLINK GENETICS CORP · (NLNK)

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Nicholas N. Vahanian
Officer — President, Chief Medical Offic
Period of report
Jan 2, 2015
Accepted (ET)
Jan 6, 2015 · 8:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001126234

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Jan 2, 2015F1,161$43.65D32,983D
Common StockF3,F2Jan 2, 2015A25,000$0.00A57,983D
Common Stockholding———52,856IBy Spouse

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F4$43.65Jan 2, 2015A81,000A—Jan 1, 2025Common Stock81,00081,000D

Explanation of responses